I was thinking hemp/cannabis but even if you put this in the healthcare products sector that current ratio is 6.94.
The revenue is a little hard to know exactly but they said during the tentative merger with PBIO that Skin Science was at 18 before landing a contract for hand sanitizer, with an initial order of 3.5 million.
Easy to figure the share structure post-split, 4,795,616. Current restricted and converted existing preferred restricted total 3,746,574 and unrestricted of 1,049,041.
To reach that price to sales with the coming O/S and a revenue rounded to 20 million the share price would need to be $28.94.
Here's the calculation used to figure P/S ratio
4,795,616 (times) $28.94 (divided by) $20,000,000 (gives P/S ratio) 6.93...
There is plenty of value here considering the current price is equal to $1.22 post-split.
CNGT!!